--
Related Articles
Australia
IMAX's Global Film Slate Likely to Support 'Robust' 2026, Wedbush Says
IMAX (IMAX) will likely benefit from an increase in the volume and quality of filmed-for-IMAX movies in 2026 through 2028, which should boost its market share, Wedbush said in a note Thursday.Meanwhile, the company will also see benefits from a worldwide box office that increasingly mixes local-language and global films, while it is also seeing a greater volume of alternative content to support revenue, and is increasing its global footprint, the note said.The positive factors are likely to help IMAX move beyond 50% earnings before interest, taxes, depreciation, and amortization, or EBITDA, margins by 2028, Wedbush said.This year and next year's "global film slate underscores IMAX's growing prominence in Hollywood and worldwide as an essential partner for major theatrical releases across genres, languages, and geographies," the investment firm said.IMAX is scheduled to report its Q1 financial results on April 30.Wedbush reiterated IMAX's outperform rating and $46 price target.Price: $36.18, Change: $-0.04, Percent Change: -0.11%
$IMAX
Research
Research Alert: Aal: Q1 Loss Narrows On Strong Revenue Growth; Fuel Remains Key Headwind
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:AAL reported Q1 adjusted loss of $0.40 per share vs. -$0.50 in the prior year and better than consensus' -$0.46. Total revenue of $13.9B, up 10.8%, beat $13.7B consensus driven by strong unit revenue growth of 7.6%. Atlantic flights were up 16.7%. We view this as strong top-line performance with the company's strategic priorities gaining traction, particularly premium revenue generation and loyalty program engagement where AAdvantage enrollments rose 25%. Full-year EPS guidance of -$0.40 to $1.10 (midpoint $0.35) exceeded the -$0.12 consensus with Q2 revenue growth expected at 13.5%-16.5%. Premium seats are expanding twice as fast as Main Cabin capacity through new deliveries, supporting higher-margin revenue streams. Total debt declined to $34.7B, the lowest since mid-2015, providing strategic flexibility. We believe management's focus on premium revenue and cost discipline positions AAL well for sustained improvement as fuel pressures moderate.
$AAL
Research
Research Alert: CFRA Lowers Rating To Buy From Strong Buy On Shares Of Blackstone Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We keep our 12-month target at $185 on a forward P/E of 29.8x our 2026 distributable earnings (DE) estimate and 2027's forward P/E at 24.2x. These valuation metrics compare to the three-year historical average at 27.8x and five-year at 25.2x. Our downgrade is a result of our tempered enthusiasm on negative brand issues within the private credit market. We were too optimistic on the DE outlook. We reduce our 2026 DE estimate by $0.50 to $6.20 (consensus $6.13) and lower 2027's by $0.30 to $7.60. Our 2026 revenue projection is $16.0B (prior $16.3B), with 2027's at $19.2B ($19.8B). Our premium valuation to the historic average reflects our view that BX and the ALT industry will show momentum into 2027 within the private market investment cycle. In 2026, we think this translates into increased incentive fees and monetization in Private Equity as well as higher management and advisory fees across all business segments. Private Credit & Insurance showed solid results and attractive fundraising from institutions.
$BX